Niche's skilled medical writing team engaged with ViiV Healthcare to quickly and efficiently develop high quality documents to support their global outreach activities. This involved:
"We frequently engaged Niche to providing editorial and medical writing support to partner organisations involved in our patient outreach programmes. We also engaged Niche to provide strategic in put on regulatory and medical affairs projects."
Niche and ViiV have had a longstanding collaboration, continuing from support provided to GSK's award winning Positive Action patient advocacy programme. Niche was invited to provide editorial and medical writing services to ViiV’s partner organisations involved in patient outreach programmes. In addition, ViiV also relied on Niche’s strategic input on various regulatory and medical affairs projects.
From very early on, ViiV’s specialist clinical ambitions were well served by Niche’s deep clinical expertise and patient-centric approach. The Niche team recognises that patient care should be paramount at every stage of clinical development. This ethos synergised well with ViiV’s patient outreach programmes.
ViiV faced major challenges in providing global access of essential medications to people living with HIV. Thus, ViiV deployed Niche’s research competencies to inform their global medications access and regulatory strategies. The team’s extensive experience in literature searches meant that they could quickly and flexibly provide ViiV with relevant information, appropriately targeted to their regulatory requirements.
Niche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study.
read moreOver a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards.
read moreFrom Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory.
read moreWhen stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.
read moreAt the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta.
read moreNiche built and coordinated the full communications strategy for this 20-institution European initiative, turning.
read moreNiche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.
read moreNiche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.
read moreFor over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical.
read moreA trusted writing partner to this Belfast-based early-phase CRO for over a decade, Niche turned BioKinetic Europe's.
read moreNiche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
